These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17961074)

  • 21. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
    Siegel F; Lu M; Roggendorf M
    J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA vaccination in the skin using microneedles improves protection against influenza.
    Song JM; Kim YC; O E; Compans RW; Prausnitz MR; Kang SM
    Mol Ther; 2012 Jul; 20(7):1472-80. PubMed ID: 22508490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination.
    Dai J; Pei D; Wang B; Kuang Y; Ren L; Cao K; Wang H; Zuo B; Shao J; Li S; Li H; Li M
    Viruses; 2012 Dec; 4(12):3606-24. PubMed ID: 23223215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
    Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
    Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
    Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
    Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Employing XIAP to enhance the duration of antigen expression and immunity against an avian influenza H5 DNA vaccine.
    Tabatabaeizadeh SE; Bassami MR; Haghparast A; Dehghani H
    Immunol Invest; 2015; 44(3):199-215. PubMed ID: 25831080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
    Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
    J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
    McKay PF; Cope AV; Mann JF; Joseph S; Esteban M; Tatoud R; Carter D; Reed SG; Weber J; Shattock RJ
    PLoS One; 2014; 9(1):e84707. PubMed ID: 24465426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
    Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
    Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.
    Kerekov NS; Ivanova II; Mihaylova NM; Nikolova M; Prechl J; Tchorbanov AI
    Immunol Res; 2014 Oct; 60(1):23-34. PubMed ID: 24515613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.
    Chen J; Zhang F; Fang F; Chang H; Chen Z
    BMC Infect Dis; 2007 Oct; 7():118. PubMed ID: 17939857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.
    Bagley K; Xu R; Ota-Setlik A; Egan M; Schwartz J; Fouts T
    Hum Vaccin Immunother; 2015; 11(9):2228-40. PubMed ID: 26042527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3d enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus.
    Tong T; Fan H; Tan Y; Xiao S; Ling J; Chen H; Guo A
    Biochem Biophys Res Commun; 2006 Sep; 347(4):845-51. PubMed ID: 16857165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
    Tjärnhage E; Brown D; Bogen B; Andersen TK; Grødeland G
    J Virol; 2023 Feb; 97(2):e0169422. PubMed ID: 36719241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Gene Delivery Vector of Agonistic Anti-Radioprotective 105 Expressed on Cell Membranes Shows Adjuvant Effect for DNA Immunization Against Influenza.
    Yamazaki T; Biswas M; Kosugi K; Nagashima M; Inui M; Tomono S; Takagi H; Ichimonji I; Nagaoka F; Ainai A; Hasegawa H; Chiba J; Akashi-Takamura S
    Front Immunol; 2020; 11():606518. PubMed ID: 33414788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
    Grødeland G; Bogen B
    Expert Rev Vaccines; 2015 Jun; 14(6):805-14. PubMed ID: 25818107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.